Web Analytics Made Easy - StatCounter

Sirolimus Tenders

Get complete information related to latest Sirolimus Tenders . from India at Classic Tenders. Search the best available tenders from Indian government tenders, domestic Sirolimus Tenders , private tenders, online tenders, tender invitation notice, business tender notices, online tenders and bidding Sirolimus Tenders .

Filter
Loading....
Loading....
Loading....
Loading....
Loading....

Bid Submission Date Range
Tender Value

Central Government/Public Sector

CTN :45335075 Due date: 05 Jun, 202605 Jun, 2026 NA
Tender For srphc82281240-coronary drug eluting stents with (1) stent on cobalt chromium alloy or platinum chromium alloy. (2) stent with coating of polymer carrier for active drug ( sirolimus everolimus or zotarolimus shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter should be from 2.5mm to 4mm and length of the stent should be 12mm to 48mm. (4) the strut thickness should be 91 micron or less. (5) stent delivery system should be monorail (single operator exchange or rapidexchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval should be enclosed in the tender bid. (9) the long term efficacy and safety of the stent in terms of target vessel revascularisation (tvr) and in-situ thrombosis (ist) should be documented / published in peer reviewed scientific journals. (10) the documents related to the efficacy and safety of the stent should be only for the brand that is offered in the tender bid (11) the manufacturer/supplier should submit proof of supply of thestent to a major government institute. unit:no [ warranty period: 30 months after the date of delivery ] ]

Central Government / Public Sector

CTN :45339400 Due date: 08 Jun, 202608 Jun, 2026 NA
Tender For hq_med_sur_zrc_zonal rate contract for supply of ph:.(153045) sirolimus eluting stent cobalt - chromium stent with abluminal coating and specialised gradient coating (no polymer coating at joint & bends). bioresorbable polymer of plcl (poly lactic acid + poly caprolactone pcl) with degradation time of 3-4 months. low concentration of sirolimus (0.8ug/mm sq) should have bio-inspired open-cell. pmda approved ]

CTN :44938485 Due date: 28 May, 202628 May, 2026 53.57 Lacs
Tender For bid to ras bid to ras bid to ras supply of 611 echs ifa gen med gem 03 fy 26 27 - clotrimazole 1 persent w per v ip plus lignocaine 2 persent w perv ip ear drop bott of 10ml , chloramphenicol 5 persent w per v clotrimazole 1 persent w per v betamethasone 0.25 persent w perv lignocaine hcl 2 persent w per v in bott of 5 ml , alprazolam 0.25 mg tab , bupropion hcl 150 mg sr tab , buspirone hcl 10 mg tab , chlordiazepoxide 10mg tab , clonazepam 0.5 mg tab , doxepin 25 mg cap , clomipramine hcl 25 mg tab , clozapine 100 mg tab , duloxetine 20 mg tab , doxepin hcl 75 mg cap , fluoxetine hcl 20 mg cap , fluvoxamine 50 mg cap , haloperidol 5 mg tab , lorazepam 1 mg tab , memantine 10 mg tab , lithium carbonate 300 mg cap per tab , mirtazapine 15 mg tab , memantine 5 mg tab , clonazepam 0.25 mg tab , risperidone 2 mg tab , aripiprazole 10 mg tab , tab fluoxamine 100 mg , olanzapine 5 mg tab , zolpidem 10 mg tab , quetiapine 50 mg tab , tab amisulpride 200 mg , tab quetiapine 100 mg , inj diclofenac 75 mg per ml 1 ml amp , glycopyrronium inhalation solution 25 mcg , pirfenidone 200 mg tab , inj methotrexate 15 mg 1 ml , budesonide 200 mcg rotacap , bromhexine 100ml syp , pioglitazone 15 mg tab , syrup terbutaline sulphate 1.25 mg plus bromhexine hcl 4 mg plus guaiphenesin 50 mg per 5 ml bottle of 100 ml , dextrose monohydrate for oral use in pack of 100 gm with or without vitamins and minerals , estriol 1 mg per gm cream tube of 15 mg , darifenacin 7.5 mg tab , solifenacin 10 mg tab , alfuzosin 10 mg tab , silodosin 4 mg tab , oxybutynin 2.5 mg tab , sildenafil citrate 50 mg tab , ascorbic acid 100 mg tab , calcium carbonate 500mg tab elemental vit d3 500 iu tab , cyclopentolate hcl 1 persent opth soln bottle of 5 ml , multi vit inj iv 2 10 ml with minimum constituents having thiamine b1 30mg per ml pyridoxine b6 30mg per ml and b12 cyanocobalamin 300 mcg per ml , ketorolac 10 mg tab , inj denosumab 60 mg per ml , dapagliflozin 5 mg tab , methyl prednisolone sodium succinate 40 mg inj , colchicine 0.5 mg tab , fexofenadine hydrochloride tab 120 mg , methyl prednisolone sodium acetate 80 mg inj , methyl prednisolone sodium succinate 0.5 gm inj , leflunomide 10 mg tab , tab methylprednisolone 4 mg , amoxycillin 250 mg plus clavulanic acid 50 mg 300 mg inj , moxifloxacin 400 mg tab , atazanavir 300 mg ritonavir 100 mg , lenvatinib 10 mg tab , levonorgestrel 0.25 mg plus ethinylestradiol 0.03mg pack of 21 tab , faropenem 300 mg tab , tenofovir 300 mg plus lamivudine 300 mg plus efavirenz 600 mg combination pill , acyclovir 200 mg tab , nevirapine 200 mg tab , eye drop brimonidine 0.2 persent plus brinzolamide 1 persent bottle of 5 ml , tab thyroxine sodium 75 mcg , antacid chewable containing dried aluminium hydroxide ip 250 mg mag hydroxide nf 250 mg methyl polysiloxane 50 mg tab , l ornithine l aspartate powder 5gm , tab l ornithin l aspartate , dexamethasone 4 mg , tab methotrexate 15 mg , clozapine 50 mg tab , ranolazine 500 mg tab , cabergoline 0.25 mg tab , norethisterone 5 mg tab tab everolimus 0.5 mg, pantaprazole40 mg +domperidone sr 10 mg tab, ethinyl estradiol 30 mcg + drosperinone 33 mg, tab, tab ibandronate 150 mg, ethinyl estradiol 0.035mg, cyproterone acetate 2mg (pack of 21 tablets), ciprofloxacin hcl 0.3% tube of 5 gm, betamethasone dipropionate 0.025% w/wm, neomycin 0.5% w/w, clotrimaz, gliclazide mr 30 mg, tab, glipizide 5mg tab, insulin highly purified isophane (human nph ), tab thyroxine sodium 12.5 mcg, glycopyrronium & formoterol fumarate powder for inhalation(box of 30 capsules), //bid details 2 / 93

CTN :45146882 Due date: 25 May, 202625 May, 2026 1.00 Crore
Tender For empanelment for the supply of cathlab items on running contract basis under kasp and other schemes of this hospital - coronary stents, des,everolimus,fda/dcgi/ce approved platinum chromium platform,polyvinylidene fluride-hexafluropropyline pvdf-hfp polymer-stent lengths8,12,16,24,28,32. stent diameter 2.25*,2.50,2.75,3.00,3.50,4.00.struct thickness 81/86 microns.nominal pressure - 11 atm,rated burst pressure 16-18 atm, des,everolimus,fda/ approved platinum chromium platform,polyvinylidene fluoride-hexafluropropylene(pvdf-hfp)polymer, des,everolimus,fda/dcgi/ce/ approved platinum chromium platform,bioabsorbable polymer plga, everolimus eluting platinum chromium stent system, des, everolimus, l 605 cobalt chromium with hybrid cell design , strut thickness- 65microns, polymer- plga diameter- 2.25, 2.5, 2.75, 3.0, 3.5,4. length- 10,13,15,18,20,24, 28, 32,36,40, 42, 44, des, everolimus, cobalt chromium strut thickness - 63 microns . diameter- 2.25,2.5,2.75,3,3.5,4. length- 8,10,13,15,18,20,24,28,32,36,40,42,44. elutes 80% of drugs along with re plga polymer in the first 20 days, dcgi approved everolimus drug eluting 65 micron strut thickness with 3 micron plla&plga. a unique proprietory coating technology basedbiodegradable polymer stent with open cell designed and flexia finished technology based cobalt chromium l605 stent.a designed for optimal strength, flexibility ,trackablity ,side branch supported,bifurcation supported and high radial strength and optimal radiopacity and excellent vessel supported stent with revers alternative link design(ral) stent, with length from 8 mm to 52 mm and diameter from 2.25 mm to 4.50 mm, ce approved everolimus eluting coronary stent system struts/cells shows a wavy pattern and are not straight with outerradius of 0.1725mm. the cell angle is between 42 degree to 57 degree with respect to different diameter. the cells are connected by link (mid to mid pattern) with a radius of 0.2700mm. these values have been validated for lower stent profile, uniform expansion, side branch access, good trackability & strong radial support. components - drug: everolimus, stent platform: cobalt chromium l605 alloy, polymer: biodegradable, catheter: ptca rapid exchange semi-compliant stent delivery catheter. drug concentration: 1.2 microgram/mm2 of stent surface area. stent diameter(mm): 2.00, 2.25, 2.50, 2.75, 3.00, 3.50, 4.00 & 4.50 & stent length (mm): 8, 13, 16, 20, 24, 28, 32, 36, 40, 43, 47 platinum-iridium radiopaque markers are precisely placed within the balloon cones for accurate stent positioning, also the difference between stent edge to marker is 0.5mm (atboth sides, proximal & distal) which prevents the dogboning during the angioplasty., ce approved sirolimus eluting coronary stent system struts/cells shows a wavy pattern and are not straight with outerradius of 0.1725mm. the cell angle is between 42 degree to 57 degree with respect to different diameter. the cells are connected by link (mid to mid pattern) with a radius of 0.2700mm. these values have been validated for lower stent profile, uniform expansion, side branch access, good trackability & strong radial support. components - drug: everolimus, stent platform: cobalt chromium l605 alloy, polymer: biodegradable, catheter: ptca rapid exchange semi-compliant stent delivery catheter. drug concentration: 1.2 microgram/mm2 of stent surface area. stent diameter(mm): 2.00, 2.25, 2.50, 2.75, 3.00, 3.50, 4.00 & 4.50 & stent length (mm): 8, 13, 16, 20, 24, 28, 32, 36, 40, 43, 47 platinum-iridium radiopaque markers are precisely placed within the balloon cones for accurate stent positioning, also the difference between stent edge to marker is 0.5mm (atboth sides, proximal & distal) which prevents the dogboning during the angioplasty., only dcgi approved everolimus eluting coronary stent system struts/cells shows a wavy pattern and are not straight with outerradius of 0.1725mm. the cell angle is between 42 degree to 57 deg

CTN :45283436 Due date: 03 Jun, 202603 Jun, 2026 NA
Tender For supply of polymer free sirolimus eluting coronary stent, with microporous surface, abluminal coating, shellac resin and 10 years of safety and efficacy data. warranty: replacement warranty against any manufacturing defect noted on the o.t. table. [ai(2026-27), item code-no: s-62284, sl no.2183] ]

CTN :44698030 Due date: 25 May, 202625 May, 2026 NA
Tender For bid to ras corrigendum : supply of biodegradable polymer coated cobalt chromium sirolimus drug eluting stent system with ultrathin 60 m , biodegradable polymer co cr sirolimus drug eluting stent with 65 microns strut thickness assorted si

Central Government / Public Sector

CTN :45267401 Due date: 02 Jun, 202602 Jun, 2026 NA
Tender For hq_med_sur_zrc_zonal rate contract for supply of ph:.(153047) biodegradable polymer sirolimus eluting coronary stent with stainless - steel platform having microporous surface, albuminal coating and shellac resin with diameters of 2.0 mm to 4.0 mm of varying length ]

Central Government/Public Sector

CTN :45254443 Due date: 03 Jun, 202603 Jun, 2026 NA
Tender For srphc82281240-coronary drug eluting stents with (1) stent on cobalt chromium alloy or platinum chromium alloy. (2) stent with coating of polymer carrier for active drug ( sirolimus, everolimus or zotarolimus shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter should be from 2.5mm to 4mm and length of the stent should be 12mm to 48mm. (4) the strut thickness should be 91 micron or less. (5) stent delivery system should be monorail (single operator exchange or rapid exchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval shouldbe enclosed in the tender bid. (9) the long term efficacy and safety of the stent in terms of target vessel revascularisation (tvr) and in-situ thrombosis (ist) should be documented / published in peer reviewed scientific journals. (10) the documents related to the efficacy and safety of the stent should be only for the brand that is offered in the tender bid (11) the manufacturer/supplier should submit proof of supply of the stent toa major government institute.[quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]

CTN :45260369 Due date: 30 May, 202630 May, 2026 NA
Tender For supply of mg plus carbidopa 10 mg tab , carbidopa 25mg plus levodopa 100 mg tab , pramipexole 1 mg tab , ropinirole 0.25 mg tab , rasagiline 1 mg tab , ethamsylate 250 mg tab , acenocoumarol tab 4 mg , acenocoumarol 1mg tab , phytomenadione vit k1mg, 0.5ml inj , choline salicylate and benalkonium chloride gel of 10 ml , ethamsylate 250 mg, 2 ml inj , mannitol 20 per 100ml , acenocoumarol 2mg tab , vitamin k 10, amp of ml , isosorbide dinitrate tab 10 mg , isosorbide, 5 mononitrate tab 20 mg , dabigatran etexilate 150 mg tab , apixaban 2.5 mg tab , esmolol 100 mg, 10 ml inj , nebivolol 5mg tab , labetalol 100 mg tab , propranolol tab 40 mg , digoxin tab 0.25 mg , digoxin 0.5 mg inj amp of 2 ml , sidenafil 25 mg tab , resperidone long acting 37.5 mg inj , quetiapine 100 mg tab , amisulpride 200 mg tab , paroxitine cr 12.5 mg tab , venlafaxine 37.5 mg tab , olanzapine 5 mg tab , venlafaxine 75 mg tab , nicorandil 5mg tab , betamethasone dipropionate usp 0.05 mg and gentamycin 1 mg, gm, tube of 20 gm , hydroquinone 2 per tube of 50 gm , isotretinoin 20 mg cap , glycerin , permethrin 5 per tube of 30 gm , triamcinolone acetate inj 10 mg, vial of 1 ml , tretinoin 0.1 per tube of 20 gm , hydroxyzine 25mg tab , clobetasole plus fusidic acid cream , alcoholic hand disinfectant rub containing 2, propanol ip 45 gm, 1, propanol ip 30 gm, ethyl hexadecyl dimethyl ammonium ethyl sulphate 0.2 gm ,mecetronium ethyl sulphate , 100 ml bott , sodium hypochloride 5 per soln , 2, proppanol 45gm, 1, propanol 30 gm ethyl hexadecyl dimehyl ammonium ethyl sulphate 0.2 gm with skin protecting substances 500 ml bott with dispenser 500 ml per bott , chloroxylenol solution potassium hydroxide, 13.6 gm, chlaroxylenon solution 50g,5.5 per ,dettol , 5 ltr pack , vasopressin 20 units, ml inj,1 ml amp , hydrogen peroxide solution with stabillizer ip ,20 volume , 500 ml bott , dopamine hcl inj 40 mg, ml in amp of 5ml , tab paraformaldehyde , cilnidipine 5 mfg tab , heparin 10 unit, ml 10 ml inj, cath flush inj , labetalol 20mg, 4ml inj amp of 4ml , frusemide inj 20 mg in amp of 2 ml , eplerenone 25 mg tab , prazosin tab 5 mg sustained release, slow release , rivaroxaban 10 tab , spironolactone 50 mg tab , bisoprolol 5 mg tab , metoprolol 12.5mg tab , terlipressin 1 mg vial plus 5ml amp of sterile diluent inj , entacavir 0.5 mg tab , sodium bicarbonate 0.5 gm tab , lactic acid bacillus sachet , dicyclomine hcl ip 20 mg plus paracetamol ip 500 mg tab , 5, amino salicylic acid enema 400mg , dicyclomine hcl 20mg inj , dicyclomine 20 mg tab , hyoscine bromide inj 20 mg, ml, 01 ml inj , mebeverine hcl 135mg tab , glycerin suppositories child size ,2g mould , , pantaprazole 40 mg plus dompendone 10 mg sustained release tab , paraffin liquid in bottle of 100 ml , rabeprazole 20mg plus domperidone 30mg sustained release tab , rifaximine 400 mg tab , ethinyl estradiol 0.035 mg,cyproterone acetate 2 mg ,pack of 21 tablets. , , clomiphene citrate 50 mg tab , mifepristone 200 mg tab , misoprostol 100 mcg tab , clotrimazole vaginal pessary 100mg , levonorgestrel 0.15 mg plus ethinylestradiol 0.03 mg ,pack of 21 tab , , oestradiol valerate 2mg tab pack of 28 , medroxy progesterone 10 mg tab , methylergometrine maleate 0.2mg amp of 1 ml , nor, ethisterone 5mg tab , oestrogen conjugated 0.625mg tab , oxytocin inj 5 oxytocic units per 0.5ml amp of 0.5ml , magnesium sulphate 50 per w, v inj , glipizide 5mg tab , carbimazole tab 5 mg , tab thyroxine sodium 12.5 mcg , neostigmine inj 0.5 mg in 1 ml ampoule , vecuronium bromide inj 4mg, ml amp of 1 ml , tacrolimus 1mg tab , tab solifenacin 5mg , oestocalcium syrup ,60 ml //bid details 2 / 125 , syp , ketorolac tromethamine 0.4 per eye drop bott of 5 ml , lotepredenol etabonate 0.5 bott of 5 ml , povidone 5 per eye drop bott of 5 ml , fluconazole 0.3 per w, v bott of 5 ml , homatropine hydrochloride,sol 2 per eye drop bott of 5 ml , cyclopentolate hcl 1 per opth soln bottle of 5 ml , natamycin 3 per in 3 ml eye drops , atropine sulph

CTN :45252804 Due date: 29 May, 202629 May, 2026 NA
Tender For supply of dglp drugs gem 13 pvms 12 series 2026 27 e e - chondroitin sulfate 4percent sterile for intraocular use , tropicamide eye solution 1percent bott of 5 ml , trypan blue 0dot6percent in vial of 1ml inj , chloramphenicol with dexamethasone polymyxin b eye ointment , atropine sulphate 1percent w v bott of 3 ml , atropine sulphate oint 1percent tube of 3 gm , bimatoprost 0dot03percent bott of 3ml , ripasudil 0dot4percent w v eye rops , nepafenac 0dot3percent with carbomer and guar eye suspension , brimonidine 0dot2percent plus timolo 0dot5percent eye drops , gatifloxacin 0dot3percent plus loteprednol 0dot5percent eye drops , moxifloxacin hcl 5mg and dexamethasone phosphate 1mg preservative free ophthalmic solution , nepafenac 0dot1percent w v eye drops , olopatadine hcl 0dot2percent ey drops with drop dispenser technology , polyethylene glycol 400 nf 0dot4percent propylene 0dot3percent , tacrolimus eye ointment 0dot1percent tube of 20gm , tropicamide 0dot8percent w v plus phenylpherine 5percent eye drops , brinzolamide bkc as preservative 0dot01percent , hyaluronidase 1500 iu inj 2ml , tafluprost 0dot0015percent w v eye drops bott of 2dot5ml with dimple technology , syp diphenhydramine 10 15 mg per 5 ml and ammonium chloride 100 150 mg sodium citrate 50 85 mg per 5 ml bottle of 100 ml , fluticasone propionate 50 mcg bp nasal spray , betahistine dihydro chloride 8mg tab , cinnarizine 25 mg tab , prochlorperazine maleate 5mg tab , clotrimazole 1percent w v ip plus lignocaine 2percent w v ip ear drop bott of 10ml , nasal decongestant adult drops xylometazoline hcl 0dot1percent w v nasal drop bottle of 10 ml , xylometazoline hcl 0dot05percent w v nasal solution for paed use bott of 10ml , caffeine citrate 20 mg ml inj 1ml vial , salmetrol 25 mcg plus fluticasone 125mg mdi 120 doses , caffeine 20mg 1ml 1ml syp , liposomal amphotericin b 10 mg vial for injection , cefaclor syp 125mg 5ml bott of 30 ml , midazolam nasal spray0dot5 mg spray 5 ml bottle , linezolid dry powder 100mg 30ml , cetrizine syp 5mg 5ml bott of 60 ml , frusemide 10 mg ml 30 ml syp , cloxacillin syp each 5 ml containing 125 mg of cloxacillin sodium bottle of 30 ml , syp baclofen 1 mg ml , cyproheptadine hcl 2 mg 5 ml bott of 100 ml , domperidone syp 1 mg ml bott of 30 ml , digoxin syp elixir 0dot05mg per ml in 30 ml packages , syp dicyclomine drops of 15 ml , norflox syp 100mg 5ml bott of 30 ml , ondansetron syp 2 mg 5ml in bott of 30 ml , phenobarbitone syp 20 mg 5 ml bott of 60 ml , iron drops paediatric containing ferrous fumerate 25mg ml vit b12 12dot5mg ml and folic acid 200mg ml bott of 15ml , prednisolone syp 5mg 5ml in bott of 30 ml , levo salbutamol syrup 1 mg 5ml bottle of 100 ml , human milk fortifier 2gm sachet , syrup calcium phosphate 80 mg 5 ml 200 ml bottle , tab isoniazid 60 mg plus rifampicin 60 mg , tab dispersable isoniazid 60 mg plus rifampicin 60 mg plus pyrazinamide 150 mg acyclovir ophth ointment 3% w/w in 5 gm tube, timolol maleate 0.5% preservative free with comod system, ciprofloxacin hcl 0.3% tube of 5 gm, cyclopentolate hcl 1% opth soln bottle of 5 ml, ciprofloxacin hcl 0.3% + dexamethasone 0.1 % bott of 5ml, cyclosporine eye drop 0.05% bott of 3 ml, flurbiprofen sodium ophthalmic sol 0.03% vial of 5 ml, gatifloxacin 0.3% eye drop bott of 5 ml, gentamicin sulphate 0.3% w/v gentamicin base with hydrocortisone acetate, homatropine hydrochloride,sol 2%, ketorolac tromethamine 0.4%, eye drops, brimonidine tartrate 0.2%, eye drops, lotepredenole tabonate 0.5% bott of 5 ml, lignocaine hyrochloride 4% topical solution //bid details 2 / 64
 Loading, Please wait...

Connect us via What's Up